Lamb R F, Going J J, Pickford I, Birnie G D
Beatson Institute for Cancer Research, Cancer Research Campaign Beatson Laboratories, Glasgow, Scotland.
Cancer Res. 1996 Feb 15;56(4):916-20.
Allelic imbalance at the NME locus on chromosome 17q21 was analyzed in colorectal cancer patients using a highly polymorphic microsatellite repeat sequence within NME1 itself. Duplicate samples of carcinoma and adjacent normal tissue was obtained by microdissection from 6 to 7-microns paraffin sections of 94 primary carcinomas (treatment years 1979-1993) and available lymph node and liver secondaries. In 55 patients informative (heterozygous) at this locus, allelic imbalance was examined in primary and secondary carcinomas. Microsatellite instability prevented assessment of allelic balance in two cases, and there was no evidence of homozygous loss at NME1 in any case analyzed. Allelic imbalance at the NME locus in carcinomas was frequent (27/53; 51%), and concordant results were obtained between primary carcinoma and secondary deposits in 30 of 33 (91%) cases. Three discordant cases showed allelic imbalance in secondary deposits but not the primary lesion. Although frequent, allelic imbalance at NME1 had no relationship to Dukes' stage at presentation or with subsequent hepatic metastasis, nor with the primary carcinoma site (proximal versus distal), tumor size, or mitotic or apoptotic index. Moreover, neither disease-free nor overall survival differed between patients with carcinomas showing NME1 allelic imbalance and patients with carcinomas that did not. Our results show that although allelic imbalance is frequent at the NME locus in primary and secondary colorectal carcinomas, there is no evidence to link this with clinical or pathological features or with metastatic potential. Microsatellite PCR and microdissection of enriched populations of carcinoma cells allowed uniformly successful analysis of samples from archival formalin-fixed paraffin-embedded tissue up to 15 years old and clear assessment of allelic imbalance in tumor specimens. Target sequences (e.g., microsatellites and minisatellites) up to approximately 200-250 bp may be reliably analyzed for allelic balance, suggesting that this method is of general utility in the genetic analysis of primary and metastatic neoplasia.
利用NME1基因内一个高度多态的微卫星重复序列,对结直肠癌患者17q21染色体上NME基因座的等位基因失衡情况进行了分析。通过显微切割从94例原发性癌(治疗年份为1979 - 1993年)的6至7微米石蜡切片以及可获得的淋巴结和肝转移灶中获取癌组织和相邻正常组织的重复样本。在该基因座具有信息性(杂合)的55例患者中,对原发性癌和继发性癌中的等位基因失衡情况进行了检测。微卫星不稳定性导致两例无法评估等位基因平衡,在任何分析的病例中均未发现NME1基因的纯合缺失。癌组织中NME基因座的等位基因失衡很常见(27/53;51%),在33例中的30例(91%)原发性癌和转移灶之间获得了一致的结果。三例不一致的病例显示转移灶存在等位基因失衡,而原发性病变未出现。尽管NME1基因座的等位基因失衡很常见,但与就诊时的Dukes分期、随后的肝转移、原发性癌部位(近端与远端)、肿瘤大小或有丝分裂或凋亡指数均无关联。此外,显示NME1等位基因失衡的癌患者与未出现该情况的癌患者之间,无病生存期和总生存期均无差异。我们的结果表明,尽管原发性和继发性结直肠癌中NME基因座的等位基因失衡很常见,但没有证据表明这与临床或病理特征或转移潜能有关。微卫星PCR和对富集的癌细胞群体进行显微切割,使得对长达15年的存档福尔马林固定石蜡包埋组织样本进行统一成功的分析,并能清晰评估肿瘤标本中的等位基因失衡。长度达约200 - 250 bp的靶序列(如微卫星和小卫星)可可靠地分析等位基因平衡,这表明该方法在原发性和转移性肿瘤的基因分析中具有普遍实用性。